{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T18:07:02Z","timestamp":1764698822385,"version":"3.37.3"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Interdisciplinary General Joint Research Grant for the Nihon University","award":["00-017"],"award-info":[{"award-number":["00-017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recently, we reported that extent of proliferation of atypical hepatocytes (atypical hepatocytes) was most important histological risk factor for development of hepatocellular carcinoma (HCC) from chronic hepatitis C or liver cirrhosis. Here, we aimed to clarify whether the atypical hepatocytes in noncancerous sections is also involved in postoperative recurrence. Furthermore, we investigated significant genes involved in the atypical hepatocytes. Association between the extent of atypical hepatocytes in noncancerous tissue and postoperative recurrence was validated in 356 patients with HCC. Next, we identified putative signature genes involved in extent of atypical hepatocytes. First, atypical hepatocytes or hepatocytes other than the atypical hepatocyte in noncancerous sections of 4 HCC patients were selectively collected by laser capture microdissection (LCM). Second, the gene expression profiles of the selected hepatocyte populations were compared using Ion AmpliSeq Transcriptome Human Gene Expression Kit (Thermo Fisher SCIENTIFIC, Waltham, MA, USA) analysis. Finally, we validated the mRNA expression of the extracted genes in noncancerous frozen liver tissue from 62 patients with HCC by RT-qPCR to identify the signature genes involved in both the extent of atypical hepatocytes and postoperative recurrence. Furthermore, the extent of atypical hepatocytes and CDT1 expression in noncancerous sections from 8 patients with HCC were also validated by selectively collecting samples using LCM. The extent of atypical hepatocytes was associated with postoperative recurrence. Of the genes that showed significant differences in expression levels between two populations, the expression of the chromatin licensing and DNA replication factor 1 (<jats:italic>CDT1<\/jats:italic>) gene was most strongly associated with the extent of atypical hepatocytes and was also associated with postoperative recurrence. Furthermore, CDT1-positive cells that exhibited stronger expression resembled those morphologically considered to be atypical hepatocytes. CDT1 and Ki-67 were colocalized in the nuclei of both hepatocytes and cancer cells. The hepatocytes in noncancerous livers were not uniform in each hepatocyte population, suggesting that the accumulation of genetic abnormalities was variable. We found that the strong degree of atypical hepatocytes and high<jats:italic>CDT1<\/jats:italic>mRNA expression represent a high carcinogenic state of the liver. Thus, we consider the evaluation of degree of these could support the personalized medicine.<\/jats:p>","DOI":"10.1038\/s41598-022-25201-6","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T15:11:51Z","timestamp":1669648311000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The proliferation of atypical hepatocytes and CDT1 expression in noncancerous tissue are associated with the postoperative recurrence of hepatocellular carcinoma"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4617-508X","authenticated-orcid":false,"given":"Mitsuhiko","family":"Moriyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1654-5385","authenticated-orcid":false,"given":"Tatsuo","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Midorikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Masuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshikatu","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motomi","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumichi","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tokio","family":"Higaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Kanemaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Miki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Sugitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadatoshi","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,28]]},"reference":[{"issue":"1","key":"25201_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/hepr.13675","volume":"52","author":"M Kudo","year":"2022","unstructured":"Kudo, M. et al. Report of the 22th Nationwide follow-up survey of primary liver cancer in Japan (2012\u20132013). Hepatol. Res. 52(1), 5\u201366 (2022).","journal-title":"Hepatol. Res."},{"issue":"20","key":"25201_CR2","doi-asserted-by":"publisher","first-page":"6217","DOI":"10.1158\/1078-0432.CCR-18-4041","volume":"25","author":"K Tatsuno","year":"2019","unstructured":"Tatsuno, K. et al. Impact of AAV2 and hepatitis B virus integration into genome on development of hepatocellular carcinoma in patients with prior hepatitis B virus infection. Clin. Cancer Res. 25(20), 6217\u20136227 (2019).","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"25201_CR3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1159\/000098240","volume":"50","author":"M Moriyama","year":"2007","unstructured":"Moriyama, M. et al. Interferon therapy improves the irregular regeneration of hepatocytes in liver in patients with C-viral chronic hepatitis and liver cirrhosis. Intervirology 50(2), 138\u2013149 (2007).","journal-title":"Intervirology"},{"issue":"5 Suppl 1","key":"25201_CR4","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","volume":"127","author":"G Fattovich","year":"2004","unstructured":"Fattovich, G., Stroffolini, T., Zagni, I. & Donato, F. Hepatocellular carcinoma in cirrhosis: Incidence and risk factors. Gastroenterology 127(5 Suppl 1), S35\u2013S50 (2004).","journal-title":"Gastroenterology"},{"issue":"7","key":"25201_CR5","first-page":"2579","volume":"36","author":"PP Anthony","year":"1976","unstructured":"Anthony, P. P. Precursor lesions for liver cancer in humans. Cancer Res. 36(7), 2579\u20132583 (1976).","journal-title":"Cancer Res."},{"issue":"12","key":"25201_CR6","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1002\/1097-0142(19830615)51:12<2197::AID-CNCR2820511208>3.0.CO;2-5","volume":"51","author":"S Watanabe","year":"1983","unstructured":"Watanabe, S. et al. Morphologic studies of the liver cell dysplasia. Cancer 51(12), 2197\u20132205 (1983).","journal-title":"Cancer"},{"issue":"9118","key":"25201_CR7","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/S0140-6736(97)08002-1","volume":"351","author":"M Shibata","year":"1998","unstructured":"Shibata, M. et al. Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection. Lancet 351(9118), 1773\u20131777 (1998).","journal-title":"Lancet"},{"issue":"3","key":"25201_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1440-1827.1995.tb03440.x","volume":"45","author":"T Uchida","year":"1995","unstructured":"Uchida, T. Small hepatocellular carcinoma: Its relationship to multistep hepato-carcinogenesis. Pathol. Int. 45(3), 175\u2013184 (1995).","journal-title":"Pathol. Int."},{"issue":"2","key":"25201_CR9","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000150367","volume":"37","author":"T Uchida","year":"1994","unstructured":"Uchida, T. Pathology of hepatitis C. Intervirology 37(2), 126\u2013132 (1994).","journal-title":"Intervirology"},{"key":"25201_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0046-8177(84)80190-2","volume":"15","author":"T Uchida","year":"1984","unstructured":"Uchida, T., Kronborg, I. & Peters, R. L. Acute viral hepatitis: morphologic and functional correlations in human livers. Hum. Pathol. 15, 267\u2013277 (1984).","journal-title":"Hum. Pathol."},{"issue":"1","key":"25201_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00000441-197507000-00004","volume":"270","author":"RL Peters","year":"1975","unstructured":"Peters, R. L. Viral hepatitis: A pathologic spectrum. Am. J. Med. Sci. 270(1), 17\u201331 (1975).","journal-title":"Am. J. Med. Sci."},{"issue":"2","key":"25201_CR12","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1053\/jhep.2001.21902","volume":"33","author":"Y Ueno","year":"2001","unstructured":"Ueno, Y., Moriyama, M., Uchida, T. & Arakawa, Y. Irregular regeneration of hepatocytes is an important factor in the hepatocarcinogenesis of liver disease. Hepatology 33(2), 357\u2013362 (2001).","journal-title":"Hepatology"},{"issue":"30","key":"25201_CR13","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.3748\/wjg.v19.i30.4887","volume":"19","author":"H Matsumura","year":"2013","unstructured":"Matsumura, H. et al. Histopathology of type C liver disease for determining hepatocellular carcinoma risk factors. World J. Gastroenterol. 19(30), 4887\u20134896 (2013).","journal-title":"World J. Gastroenterol."},{"key":"25201_CR14","first-page":"1","volume":"2019","author":"Liver Cancer Study Group of Japan. The General Rules for the Clinical and Pathological Study of Primary Liver Cancer","year":"2019","unstructured":"Liver Cancer Study Group of Japan. The General Rules for the Clinical and Pathological Study of Primary Liver Cancer. 6th ed. Revised Version. Tokyo: Kanehara-shuppan 2019, 1\u201393 (2019).","journal-title":"Revised Version. Tokyo: Kanehara-shuppan"},{"issue":"6","key":"25201_CR15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1600-0676.1990.tb00481.x","volume":"10","author":"K Suzuki","year":"1990","unstructured":"Suzuki, K. et al. Expression of pre-S1, pre-S2, S and X peptides in relation to viral replication in livers with chronic hepatitis B. Liver 10(6), 355\u2013364 (1990).","journal-title":"Liver"},{"issue":"5","key":"25201_CR16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1440-1827.1993.tb01137.x","volume":"43","author":"T Uchida","year":"1993","unstructured":"Uchida, T. et al. Histological difference between complete responders and non-responders to interferon therapy of the livers of patients with chronic hepatitis C. Acta Pathol. Japon. 43(5), 230\u2013236 (1993).","journal-title":"Acta Pathol. Japon."},{"issue":"3","key":"25201_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0168-8278(05)80283-1","volume":"18","author":"T Uchida","year":"1993","unstructured":"Uchida, T. et al. Detection of precore\/core-mutant hepatitis B virus genome in patients with acute or fulminant hepatitis without serological markers for recent HBV infection. J. Hepatol. 18(3), 369\u2013372 (1993).","journal-title":"J. Hepatol."},{"issue":"2","key":"25201_CR18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/0928-4346(93)90052-H","volume":"1","author":"M Moriyama","year":"1993","unstructured":"Moriyama, M. et al. Ultrastructural study of HBx antigen in liver from chronic hepatitis B patients. Int. Hepatol. Commun. 1(2), 80\u201382 (1993).","journal-title":"Int. Hepatol. Commun."},{"issue":"2","key":"25201_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0168-8278(00)80068-9","volume":"32","author":"F Komine","year":"2000","unstructured":"Komine, F. et al. Telomerase activity of needle-biopsied liver samples: its usefulness for diagnosis and judgement of efficacy of treatment of small hepatocellular carcinoma. J. Hepatol. 32(2), 235\u2013241 (2000).","journal-title":"J. Hepatol."},{"issue":"4","key":"25201_CR20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1046\/j.1365-2893.2000.00235.x","volume":"7","author":"H Matsumura","year":"2000","unstructured":"Matsumura, H. et al. Natural course of progression of liver fibrosis in Japanese patients with chronic liver disease type C-a study of 527 patients at one establishment. J. Viral Hepatitis 7(4), 268\u2013275 (2000).","journal-title":"J. Viral Hepatitis"},{"issue":"5","key":"25201_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1034\/j.1600-0676.2000.020005397.x","volume":"20","author":"M Moriyama","year":"2000","unstructured":"Moriyama, M. et al. Hepatitis G virus coinfection influences the liver histology of patients with chronic hepatities C. Liver 20(5), 397\u2013404 (2000).","journal-title":"Liver"},{"issue":"1","key":"25201_CR22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/jmv.1020","volume":"64","author":"M Moriyama","year":"2001","unstructured":"Moriyama, M. et al. Histopathologic impact of TT virus infection on the liver of type C chronic hepatitis and liver cirrhosis in Japan. J. Med. Virol. 64(1), 74\u201381 (2001).","journal-title":"J. Med. Virol."},{"issue":"4","key":"25201_CR23","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/jmv.10149","volume":"67","author":"M Mikuni","year":"2002","unstructured":"Mikuni, M., Moriyama, M., Tanaka, N., Abe, K. & Arakawa, Y. SEN virus infection does not affect the progression of non-A to -E liver disease. J. Med. Virol. 67(4), 624\u2013629 (2002).","journal-title":"J. Med. Virol."},{"issue":"4","key":"25201_CR24","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/cncr.10732","volume":"95","author":"H Yamagami","year":"2002","unstructured":"Yamagami, H. et al. Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases. Cancer 95(4), 824\u2013834 (2002).","journal-title":"Cancer"},{"issue":"4","key":"25201_CR25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1386-6346(02)00307-8","volume":"25","author":"M Moriyama","year":"2003","unstructured":"Moriyama, M. et al. The clinical significance of serum KL-6 levels in patients with type C liver diseases. Hepatol. Res. 25(4), 385\u2013395 (2003).","journal-title":"Hepatol. Res."},{"issue":"2","key":"25201_CR26","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1478-3231.2005.01076.x","volume":"25","author":"M Moriyama","year":"2005","unstructured":"Moriyama, M. et al. SEN virus infection influences the pathological findings in liver but does not affect the incidence of hepatocellular carcinoma in patients with chronic hepatitis C and liver cirrhosis. Liver Int. 25(2), 226\u2013235 (2005).","journal-title":"Liver Int."},{"issue":"5","key":"25201_CR27","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1159\/000187720","volume":"51","author":"S Matsuoka","year":"2009","unstructured":"Matsuoka, S. et al. Influence of occult hepatitis B virus coinfection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C. Intervirology 51(5), 352\u2013361 (2009).","journal-title":"Intervirology"},{"issue":"1","key":"25201_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.7150\/ijms.17202","volume":"14","author":"K Nirei","year":"2017","unstructured":"Nirei, K. et al. Steatosis influences the clinical profiles and long-term outcomes of interferon-treated chronic hepatitis C and liver cirrhosis patients. Int. J. Med. Sci. 14(1), 45\u201352 (2017).","journal-title":"Int. J. Med. Sci."},{"key":"25201_CR29","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1186\/s12864-015-2270-1","volume":"16","author":"W Li","year":"2015","unstructured":"Li, W. et al. Comprehensive evaluation of AmpliSeq transcriptome, a novel targeted whole transcriptome RNA sequencing methodology for global gene expression analysis. BMC Genomics 16, 1069 (2015).","journal-title":"BMC Genomics"},{"key":"25201_CR30","doi-asserted-by":"publisher","first-page":"8221","DOI":"10.1371\/journal.pone.0198221","volume":"13","author":"AC Papp","year":"2018","unstructured":"Papp, A. C. et al. Ampliseq transcriptome analysis of human alveolar and monocyte-derived macrophages over time in response to Mycobacterium tuberculosis infection. PLoS ONE 13, 8221 (2018).","journal-title":"PLoS ONE"},{"issue":"1","key":"25201_CR31","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1038\/s41598-020-59707-8","volume":"10","author":"K Kanemaru","year":"2020","unstructured":"Kanemaru, K., Suzuki, J., Taiko, I. & Iino, M. Red fluorescent CEPIA indicators for visualization of Ca2+ dynamics in mitochondria. Sci. Rep. 10(1), 2835. https:\/\/doi.org\/10.1038\/s41598-020-59707-8 (2020).","journal-title":"Sci. Rep."},{"issue":"3","key":"25201_CR32","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3892\/mmr.2014.2914","volume":"11","author":"LT Li","year":"2015","unstructured":"Li, L. T., Jiang, G., Chen, Q. & Zheng, J. N. Ki67 is a promising molecular target in the diagnosis of cancer (review). Mol. Med. Rep. 11(3), 1566\u20131572 (2015).","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"25201_CR33","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1159\/000346475","volume":"84","author":"K Kontzoglou","year":"2013","unstructured":"Kontzoglou, K. et al. Correlation between Ki67 and breast cancer prognosis. Oncology 84(4), 219\u2013225 (2013).","journal-title":"Oncology"},{"key":"25201_CR34","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12885-021-07880-y","volume":"21","author":"M Zeng","year":"2021","unstructured":"Zeng, M. et al. The relationship between the expression of Ki-67 and the prognosis of osteosarcoma. BMC Cancer 21, 210 (2021).","journal-title":"BMC Cancer"},{"key":"25201_CR35","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1007\/s10517-020-04781-1","volume":"168","author":"AM Avdalyan","year":"2020","unstructured":"Avdalyan, A. M., Ivanov, A. A., Lushnikova, E. L., Molodykh, O. P. & Vikhlyanov, I. V. The relationship of immunoexpression of Ki-67 and Hsp70 with clinical and morphological parameters and prognosis of papillary thyroid cancer. Bull. Exp. Biol. Med. 168, 688\u2013693 (2020).","journal-title":"Bull. Exp. Biol. Med."},{"key":"25201_CR36","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.urolonc.2017.05.004","volume":"35","author":"A Berlin","year":"2017","unstructured":"Berlin, A. et al. Prognostic role of Ki-67 score in localized prostate cancer: A systematic review and meta-analysis. Urol. Oncol. 35, 499\u2013506 (2017).","journal-title":"Urol. Oncol."},{"key":"25201_CR37","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1046\/j.1365-2559.2003.01613.x","volume":"42","author":"M Duchrow","year":"2003","unstructured":"Duchrow, M., Ziemann, T., Windh\u00f6vel, U., Bruch, H. P. & Broll, R. Colorectal carcinomas with high MIB-1 labelling indices but low pKi67 mRNA levels correlate with better prognostic outcome. Histopathology 42, 566\u2013574 (2003).","journal-title":"Histopathology"},{"issue":"7","key":"25201_CR38","first-page":"10235","volume":"8","author":"Y Luo","year":"2015","unstructured":"Luo, Y. et al. Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: A meta-analysis. Int. J. Clin. Exp. Med. 8(7), 10235\u201310247 (2015).","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"2","key":"25201_CR39","first-page":"2574","volume":"15","author":"Y Cao","year":"2018","unstructured":"Cao, Y. et al. Prediction of longterm survival rates in patients undergoing curative resection for solitary hepatocellular carcinoma. Oncol. Lett. 15(2), 2574\u20132582 (2018).","journal-title":"Oncol. Lett."},{"issue":"4","key":"25201_CR40","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1159\/000478963","volume":"42","author":"CK Yang","year":"2017","unstructured":"Yang, C. K. et al. Genome-wide association study of MKI67 expression and its clinical implications in HBV-related hepatocellular carcinoma in southern China. Cell Physiol. Biochem. 42(4), 1342\u20131357 (2017).","journal-title":"Cell Physiol. Biochem."},{"issue":"6164","key":"25201_CR41","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/332546a0","volume":"332","author":"JJ Blow","year":"1988","unstructured":"Blow, J. J. & Laskey, R. A. A role for the nuclear envelope in controlling DNA replication within the cell cycle. Nature 332(6164), 546\u2013548 (1988).","journal-title":"Nature"},{"issue":"6778","key":"25201_CR42","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/35007110","volume":"404","author":"H Nishitani","year":"2000","unstructured":"Nishitani, H., Lygerou, Z., Nishimoto, T. & Nurse, P. The Cdt1 protein is required to license DNA for replication in fission yeast. Nature 404(6778), 625\u2013628 (2000).","journal-title":"Nature"},{"issue":"2","key":"25201_CR43","first-page":"136","volume":"2","author":"T Kosaka","year":"2014","unstructured":"Kosaka, T. et al. Potent increased risk of the initiation of DNA replication in human prostate cancer with the use of 5\u03b1-reductase inhibitors. Am. J. Clin. Exp. Urol. 2(2), 136\u2013144 (2014).","journal-title":"Am. J. Clin. Exp. Urol."},{"issue":"3","key":"25201_CR44","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s11605-015-2960-7","volume":"20","author":"D Karavias","year":"2016","unstructured":"Karavias, D. et al. Overexpression of CDT1 is a predictor of poor survival in patients with hepatocellular carcinoma. J. Gastrointest. Surg. 20(3), 568\u2013579 (2016).","journal-title":"J. Gastrointest. Surg."},{"issue":"1","key":"25201_CR45","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/s41598-017-00998-9","volume":"7","author":"R Mahadevappa","year":"2017","unstructured":"Mahadevappa, R. et al. The prognostic significance of Cdc6 and Cdt1 in breast cancer. Sci. Rep. 7(1), 985 (2017).","journal-title":"Sci. Rep."},{"issue":"2","key":"25201_CR46","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1158\/1535-7163.MCT-17-0083","volume":"17","author":"V Vanderdys","year":"2018","unstructured":"Vanderdys, V. et al. The neddylation inhibitor Pevonedistat (MLN4924) suppresses and radiosensitizes head and neck squamous carcinoma cells and tumors. Mol. Cancer Ther. 17(2), 368\u2013380 (2018).","journal-title":"Mol. Cancer Ther."},{"issue":"4","key":"25201_CR47","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s10620-018-4961-3","volume":"63","author":"Z Yu","year":"2018","unstructured":"Yu, Z., Wang, R., Chen, F., Wang, J. & Huang, X. Five novel oncogenic signatures could be utilized as AFP-related diagnostic biomarkers for hepatocellular carcinoma based on next-generation sequencing. Dig. Dis. Sci. 63(4), 945\u2013957 (2018).","journal-title":"Dig. Dis. Sci."},{"issue":"7","key":"25201_CR48","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1074\/jbc.C500464200","volume":"281","author":"J Hu","year":"2006","unstructured":"Hu, J. & Xiong, Y. An evolutionarily conserved function of proliferating cell nuclear antigen for Cdt1 degradation by the Cul4-Ddb1 ubiquitin ligase in response to DNA damage. J. Biol. Chem. 281(7), 3753\u20133756 (2006).","journal-title":"J. Biol. Chem."},{"key":"25201_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.721644","volume":"11","author":"C Cai","year":"2021","unstructured":"Cai, C. et al. CDT1 is a novel prognostic and predictive biomarkers for hepatocellular carcinoma. Front. Oncol. 11, 721644 (2021).","journal-title":"Front. Oncol."},{"issue":"1","key":"25201_CR50","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1038\/s41467-019-10321-x","volume":"10","author":"P Coulombe","year":"2019","unstructured":"Coulombe, P. et al. The ORC ubiquitin ligase OBI1 promotes DNA replication origin firing. Nat. Commun. 10(1), 2426 (2019).","journal-title":"Nat. Commun."},{"key":"25201_CR51","first-page":"4","volume":"3","author":"F Feo","year":"2015","unstructured":"Feo, F. & Pascale, R. M. Multifocal hepatocellular carcinoma: Intrahepatic metastasis or multicentric carcinogenesis?. Ann. Transl. Med. 3, 4 (2015).","journal-title":"Ann. Transl. Med."},{"issue":"80","key":"25201_CR52","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1158\/0008-5472.CAN-20-0225","volume":"15","author":"Y Midorikawa","year":"2020","unstructured":"Midorikawa, Y. et al. Accumulation of molecular aberrations distinctive to hepatocellular carcinoma progression. Cancer Res. 15(80), 3810\u20133819 (2020).","journal-title":"Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25201-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25201-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25201-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T16:50:24Z","timestamp":1728492624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25201-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,28]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["25201"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-25201-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2022,11,28]]},"assertion":[{"value":"4 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Mitsuhiko Moriyama; Towa Pharmaceutical Co., Ltd. The other authors have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20508"}}